Leveraging Machine Learning to Accelerate Drug Development

Grace FCMS is a U.S.-based CDMO supporting small molecule APIs, RSMs, and peptide building blocks from development to commercial production.

SYLOID® FP silica combines adsorption, particle size, density, and surface area to reduce excipients, simplify formulations, and improve efficiency.

Explore the role of kilo labs in small molecule development and how Grace’s scale-up approach helps improve manufacturing readiness.

Discover Grace’s comprehensive pharmaceutical solutions portfolio, including our North American CDMO capabilities for small molecule development and manufacturing, and custom engineered silica products. 

This article explores how complex peptide building blocks can help improve peptide therapeutics by extending half-life, increasing potency, and enhancing patient convenience. Partnering early with an experienced, compliant manufacturing provider can help ensure a reliable supply of high-quality peptide building blocks while addressing complex development, analytical, and regulatory requirements.

Discover Grace's range of magnetic separation technology for in-vitro diagnostics. VYVID™ Superparamagnetic silica beads are ideal for rapid isolation and purification of nucleic acids, eliminating the need for columns and centrifugations.